Metabolomics Market

Major Players in the Metabolomics Market Consider New Product Launch, Agreements, Partnerships, and Collaborations as the Key Strategies to Expand Their Share in the Market

The metabolomics market is consolidated at the top, wherein the top 10 players accounted for nearly 75% of the market share in 2013. Majority of the leading players in the market are based in developed countries across North America and Europe.

In this market, Thermo Fisher Scientific, Inc. (U.S.) and Danaher Corporation (U.S.) were the leading players with market shares of 25% and 23%, respectively, in 2013. Thermo Fisher Scientific has a diversified product portfolio, which includes a wide range of analytical products including liquid chromatography, gas chromatography systems. The company’s leading position in the market in 2013 is attributed to its strong network, with a geographic presence in over 150 countries. Furthermore, the company focuses on various development strategies such as new product launches, acquisitions, and expansions.

The key strategies adopted by players in the global metabolomics market are new product launches, mergers and acquisitions, agreements and collaborations, and expansions. Apart from Thermo Fisher Scientific, Inc. (U.S.) and Danaher Corporation (U.S.), some other leading players in this market are Waters Corporation (U.S.), Agilent Technologies (U.S.), Metabolon, Inc. (U.S.), Shimadzu Corporation (Japan), Bruker Corporation (U.S.), and Biocrates Life Sciences AG. (Austria).

In order to maintain their leadership position, many players in this market used the strategies of agreements, partnerships, and collaborations. Some of the major players aim to either expand their product portfolio or increase their geographic presence. While organic expansion has been followed by some companies, majority of the top players have adopted mergers and acquisitions as their key growth strategy.

Related Reports:

Metabolomics Market by Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry), Application (Biomarker & Drug Discovery, Nutrigenomics) & by Indication (Oncology, Cardiology) - Global Forecast to 2019
https://www.marketsandmarkets.com/Market-Reports/metabolomics-technology-market-900.html

Contact:
Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com

Report Code
BT 2550
Published ON
Mar, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Metabolomics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved